Charlestown, MA, United States of America

Brian D Dynlact

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian D Dynlact. Retrieved from https://idiyas.com/inventor/brian-d-dynlact

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian D Dynlact: Innovator in RNA Polymerase Research

Introduction

Brian D Dynlact is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of RNA polymerase transcription. His work has implications for pharmaceuticals, diagnosis, and therapy.

Latest Patents

Dynlact holds a patent for the "TATA-binding protein associated factor, nucleic acids." This patent discloses TATA-binding protein associated factors (TAFs), which are nuclear proteins involved in RNA polymerase I, II, and III transcription. The methods and compositions outlined in his patent are valuable for developing new pharmaceuticals and therapeutic approaches.

Career Highlights

Brian D Dynlact is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential applications in medical science and biotechnology.

Collaborations

Dynlact has collaborated with esteemed colleagues such as Robert Tjian and Lucio Comai, further enhancing the impact of his research through shared expertise and innovation.

Conclusion

Brian D Dynlact is a prominent figure in the realm of RNA polymerase research, with a patent that holds promise for future medical advancements. His contributions to the field are noteworthy and continue to influence the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…